Archive


Category: ~$4B

  • Bayer Acquires Asklepios for ~$4B

    Shots: Bayer acquires AskBio for $2B as upfront and ~2B as milestones with 75% of the milestones to be paid during the next five years. The transaction is expected to be close in Q4’20 The focus of the acquisition is to foster Bayer’s cell and gene therapy platform with the potential to bring treatments to […]